The FDA failed to monitor the prescription of a highly potent opioid for years


Thousands of patients were improperly prescribed a highly potent and restricted class of fentanyl, an opioid 100 times more powerful than morphine, between 2012 and 2017, reports CNN.
A paper published by the Journal of the American Medical Association, which was based on nearly 5,000 pages of Food and Drug Administration reports and other documents, described how nearly every party involved in the medical profession — from the FDA and drug companies to doctors and pharmacists — were in part culpable of negligence, allowing the medicine to fall into the wrong hands.
This class of fentanyl is meant only for cancer patients who are experiencing "breakthrough pain" and who have already been prescribed "around-the-clock opioids," writes CNN. Because of its potency, the FDA created a program to monitor prescription of the drug in 2011. The research, however, found that anywhere from 34.6 to 55.4 percent of patients, or about 12,900 people who received the treatments were not, in fact, cancer patients, and were "opioid-nontolerant" or prescribed the drug for conditions such as arthritis. Fentanyl was involved in about 28 percent of drug overdose deaths in 2016, more than any other drug.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The prescribing of this medicine was supposed to be closely monitored and contained but was not," G. Caleb Alexander, a senior author of the study and director of the Johns Hopkins Bloomberg School of Public Health said, per CNN. "What we found was that several years after the program was started, there were alarming deficiencies identified, and yet little was done by the FDA and drug manufacturers to effectively address these problems."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments